Deal reflects Liberty Mutual\'s conviction to its focused Asia Pacific strategy BOSTON,March 3,2025-- Liberty Mutual Insurance has agreed to sell its operations in Thailand and Vietnam to Chubb Limit
READ MORESTOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]
BARCELONA,Spain,March 5,2025-- On March 3,as the global communications and technology community converged in Barcelona,forMWC Barcelona 2025,Yangtze Optical Fibre and Cable Joint Stock Limited Company
US-based CPTO to accelerate platform innovation SINGAPORE,May 24,2024-- OutSystems,a global leader in enterprise low-code application development,today announced Luis Blando as its Chief Product and
SUZHOU,ChinaandROCKVILLE,Md.,May 24,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in developing novel therapies for cancer,chronic hepatitis B (CHB),and age-related dis
The unique event,which is among the first global events created to build excitement for the upcoming Olympic Games,sees French andSingaporeans athletes and artists coming together to revitalise the ic
The ELECTRA and ELEVATE studies were designed to overcome different resistance mechanisms and improve patient outcomes with oral-oral combination options.
Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression,including in patients with PD-L1 CPS<5.
RIYADH,Saudi Arabia,May 24,2024-- Recently in Riyadh,Newrizon,a startup dedicated in electrifying and revolutionizing urban delivery vehicles,signed dealership agreement and intent purchase order with
NINGBO,China,May 25,2024-- On the morning of May 23,the premier exhibition of "Ningbo in Light and Shadow" was launched in Cambodia. Chen Cong,Minister-Counsellor of the Chinese Embassy in
Singapore\'s tech ambitions hinge on developing a robust talent pool in data science,crucial for leadership in AI and technology.
MELBOURNE,Australia,May 27,2024-- Telix Pharmaceuticals Limited (ASX: TLX,Telix,the Company) today announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Ad
BEIJING,May 27,2024-- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH; HKEX: 2390),a leading online content community in China,today announced that it will report its unaudited fin
© OfficialAffairs
